Zelira stock jumps 120% after US$33m deal by Adam Sheldon January 19, 2026January 19, 2026 Zelira Therapeutics shares more than doubled in value after the company locked in a US$32.98 million […]
US FDA rejects Neurotech application for orphan drug status by Steve Jones October 8, 2024February 25, 2025
US moves closer to cannabis downgrade as FDA finds ‘credible evidence’ of medical benefits by Steve Jones January 18, 2024July 11, 2024
Recreational cannabis bill introduced to US House of Representatives by Hannah Adler November 16, 2021April 29, 2024
Company news: MGC Pharma; AusCann; Creso Pharma; Canopy Growth by Martin Lane September 16, 2021April 26, 2024
Company news: Cannasouth; MGC Pharmaceuticals; Creso Pharma; Incannex; Medlab by Martin Lane July 19, 2021April 26, 2024